China

INCTR Educational Workshop on Clinical Trials in China

INCTR will be helping to train clinical investigators in developing countries through clinical trials workshops. Shown here, the participants and faculty of the workshop which took place in March, in Beijing, China, which was sponsored by Eli Lilly.

In conjunction with the Chinese Society of Clinical Oncology, and supported by Eli Lilly, INCTR held a three-day educational workshop on the Value and Conduct of Clinical Trials in China. There were 37 participants and 16 faculty members from INCTR, the National Cancer Institute, Bethesda, the International Agency for Research on Cancer, the World Health Organization, St Bartholomew's Hospital, London, the International Drug Development Institute, Brussels, the Chinese Academy of Medical Sciences, the Chinese Society of Clinical Oncology and the Chinese State Drug Administration.

Dr Lorenzo Tallarigo, President of Intercontinental Operations for Eli Lilly, participated in the opening ceremony. Six officials represented the Chinese Society of Clinical Oncology.

The workshop covered all aspects of clinical trials, including design, ethical considerations, regulations, documents, management, quality control, analysis and presentation of results and was set in the context of cancer control in China. The workshop appeared to be well-appreciated by the participants.

We anticipate developing several educational tools from the workshop, again with the support of Eli Lilly, who sent 11 people to this workshop. An edited video of the meeting will be available, and the presentations will be assembled on a compact disc that will be made available for educational and teaching purposes. INCTR is considering making the CD material available on its website, and would appreciate feedback as to whether this would be useful.

We hope to facilitate additional workshops of this kind, focused primarily on training of clinical investigators, in other world regions. Interested parties should contact the INCTR.